CIHR Projects

Browse 3648 CIHR-funded research projects

Search & Filter Projects
Clear All
Showing 1-50 of 3648 projects

PI: Kao, Dina H

Primary Clostridioides difficile infection (pCDI) is a gastrointestinal infection that presents with diarrhea, fever and abdominal pain and is often resistant to antibiotic therapy. pCDI is often a c…

Unclear Clinical
$278,485
Year: 2022
Infection and Immunity
View Details

PI: Pinto, Andrew D; Keynan, Yoav; Greiver, Michelle; Jüni, Peter; Lee, Todd C; McDonald, Emily G; Murthy, Srinivas; Selby, Peter L

While public health measures and vaccines have reduced the spread of SARS-CoV-2, most scientists predict this virus will be endemic and new variants will emerge. Effective and affordable medications …

Unclear Clinical
$1,250,000
Year: 2022
Infection and Immunity
View Details

PI: Daneman, Nick; Murthy, Srinivas; Yamamura, Deborah L; Fowler, Robert A; Johnstone, Jennie; Lee, Todd C; MacFadden, Derek R; McDonald, Emily G; Paterson, David L; Rogers, Benjamin A; Yahav, Dafna

Bloodstream infections are a leading cause of death in Canada and worldwide, yet remain understudied, such that we do not know the best treatment strategies to be sure to cure the infection while min…

Unclear Clinical
$2,919,785
Year: 2022
Infection and Immunity
View Details

PI: Coburn, Bryan A; Hota, Susy S; Kain, Kevin C; MacFadden, Derek R; Walmsley, Sharon L

Antimicrobial resistant organism are a growing global threat to health. As the number and abundance of antimicrobial resistant organisms increases, both common infections (such as urinary tract infec…

Unclear Clinical
$695,739
Year: 2022
Infection and Immunity
View Details

PI: Hawkes, Michael T; Meier-Stephenson, Vanessa; Pandey, Manisha; Tyrrell, D. Lorne J; Tyrrell, Gregory J

Group A streptococcus (Strep A) is a germ that causes several diseases, ranging from sore throat to devastating flesh-eating disease and rheumatic fever (heart disease). We have come up with new vacc…

Unclear Biomedical
$536,665
Year: 2022
Infection and Immunity
View Details

PI: Smaill, Fiona M; Comeau, Jeannette L; Gauvreau, Gail M; Halperin, Scott A; Langley, Joanne M; Loeb, Mark B; Miller, Matthew S; Satia, Imran; Wang, Jun; Xing, Zhou

Despite the benefit of current COVID vaccines in preventing severe disease and death, these vaccines are relatively poor at preventing infection with new variants like Omicron and work less well in t…

Unclear Biomedical
$8,266,315
Year: 2022
Infection and Immunity
View Details

PI: Pinto, Andrew D; Keynan, Yoav; Greiver, Michelle; Jüni, Peter; Lee, Todd C; McDonald, Emily G; Murthy, Srinivas; Selby, Peter L

While public health measures and vaccines have reduced the spread of SARS-CoV-2, most scientists predict this virus will be endemic and new variants will emerge. Effective and affordable medications …

Unclear Clinical
$5,000,000
Year: 2022
Infection and Immunity
View Details

PI: Banerjee, Arinjay

Betacoronavirus (beta-CoV) is one of four genera of coronaviruses (CoVs) that includes severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Middle East respiratory syndrome coronavirus (M…

Unclear Biomedical
$400,000
Year: 2022
Infection and Immunity
View Details

PI: Khan, Omar F

Donated organs infected with incurable cytomegalovirus (CMV) are unsafe for transplant recipients. The goal of this project is to clear CMV from harvested organs. Clearance is achieved using a smart …

Unclear Biomedical
$300,000
Year: 2022
Infection and Immunity
View Details

PI: Colpitts, Che C

The COVID-19 pandemic has underscored the severe threat posed by emerging coronaviruses. In the absence of effective broadly-acting antiviral therapies against coronaviruses, we are vulnerable to cor…

Unclear Biomedical
$300,000
Year: 2022
Infection and Immunity
View Details

PI: Grant, Michael D

Antiretroviral drugs prolong the life and health of persons living with human immunodeficiency virus (HIV), but since these drugs do not eliminate HIV, treatment needs to continue for life. In additi…

Unclear Biomedical
$100,000
Year: 2022
Infection and Immunity
View Details

PI: Deziel, Eric

Pseudomonas aeruginosa is a prevalent opportunistic human pathogen. Individuals who are immunocompromised or have breaches in normal barriers are especially susceptible to infections. «Quorum sensing…

Unclear Biomedical
$100,000
Year: 2022
Infection and Immunity
View Details

PI: Parkins, Michael D; Conly, John M; Hubert, Casey

When bacteria evolve, they can resist antibiotics, making infections harder to treat. As well, their risk of spreading, and causing severe illness and death increases. These antibiotic-resistant orga…

Unclear Biomedical
$100,000
Year: 2022
Infection and Immunity
View Details

PI: Savchenko, Alexei

Yeast species of the Candida genus are the primary cause of opportunistic infections that represent a major public health problem. The spectrum of diseases caused by Candida species ranges from vagin…

Unclear Biomedical
$100,000
Year: 2022
Infection and Immunity
View Details

PI: Creuzenet, Carole

Helicobacter pylori (HP) colonizes chronically ~50% of the world's population, causing gastric tissue inflammation and gastric ulcers or cancers. In light of rising antibiotic resistance, curtailing …

Unclear Biomedical
$100,000
Year: 2022
Infection and Immunity
View Details

PI: Tremblay, Marie-Ève; Ben-Azu, Benneth; Frenkel, Dan

Discoveries spanning the last decade have provided essential insights into Alzheimer's disease by identifying, as an important risk factor, immune challenges that affect microglia, the brain's immune…

Unclear Biomedical
N/A
Year: 2022
Infection and Immunity
View Details

PI: Victoria Ansalem, Anil Kumar

Coronavirus disease-19 (Covid-19) pandemic is the biggest global health crisis in recent history, resulting in over 4.5 million deaths worldwide. Covid-19 is caused by SARS-Coronavirus-2, a novel cor…

Unclear Biomedical
$96,270
Year: 2022
Infection and Immunity
View Details

PI: Cestari, Igor; Alonso, Guillermo D; Qvit, Nir

Chagas disease (ChD) is a global health threat affecting over 8 million people and caused by the parasite Trypanosoma cruzi (T. cruzi). ChD is found primarily in South and Central America but has spr…

Unclear Biomedical
N/A
Year: 2022
Infection and Immunity
View Details

PI: Richard, Dave; Abdel Hamid, Muzamil M; Florentin, Anat

Malaria is one of the world's most common infectious diseases, with approximately 241 million cases each year and 627 000 deaths, and thus represents one of the most devastating global public health …

Unclear Biomedical
N/A
Year: 2022
Infection and Immunity
View Details

PI: Falzarano, Darryl

Novel adjuvants for vaccines are highly desirable, especially if they can be synthesized instead of being derived from natural products. Additionally, the adjuvant should be capable of inducing a gre…

Unclear Biomedical
$193,890
Year: 2021
Infection and Immunity
View Details

PI: Zarychanski, Ryan; Lawler, Patrick R; Turgeon, Alexis F

Community acquired pneumonia (CAP) is an acute infection of the lungs acquired outside of a hospital setting. CAP is one of the most common causes of mortality in the world and results in critical il…

Unclear Clinical
$3,961,936
Year: 2022
Infection and Immunity
View Details

PI: Harrison, Joe J

Biofilms are slime-covered groups of microbes that stick to each other and to surfaces. Biofilms are responsible for many chronic infections that defeat the immune system and are highly resistant to …

Unclear Biomedical
$914,176
Year: 2022
Infection and Immunity
View Details

PI: Brown, Eric D

There have been no truly new antibiotics antibiotics discovered in more than thirty years. During the same time we have seen an alarming increase in reports of "superbugs" with resistance to existing…

Unclear Biomedical
$956,250
Year: 2022
Infection and Immunity
View Details

PI: Hoa, Sabrina A

Scleroderma (or systemic sclerosis) is a rare but life-threatening disease in which the immune system attacks its own tissues, leading to excessive scarring (fibrosis) of the skin and internal organs…

Unclear Clinical
$346,640
Year: 2022
Infection and Immunity
View Details

PI: Ohashi, Pamela S

Immunotherapy for cancer involves using the immune system to fight cancer. One key cell type is a T cell, which is a type of white blood cell that has the potential to kill tumor cells. Another way t…

Unclear Biomedical
$860,626
Year: 2022
Infection and Immunity
View Details

PI: Ohashi, Pamela S

One population of white blood cells, called T cells, is known to have the ability to kill tumor cells. Clinical studies have shown that augmenting the function of these T cells using a particular ant…

Unclear Biomedical
$956,250
Year: 2022
Infection and Immunity
View Details

PI: Corcoran, Jennifer A

Kaposi's sarcoma-associated herpesvirus (KSHV) is the infectious cause of Kaposi's sarcoma (KS), an unusual skin cancer with a bruise-like appearance which develops from the unrestricted growth of ce…

Unclear Biomedical
$918,000
Year: 2022
Infection and Immunity
View Details

PI: Murooka, Thomas T

Antiretroviral therapy (ART) blocks HIV replication and extends the life of people living with HIV (PLHIV). However, it does not eliminate the virus from the body, requiring ART lifelong. Therefore, …

Unclear Biomedical
$719,100
Year: 2022
Infection and Immunity
View Details

PI: Sorbara, Matthew T

The gastrointestinal tract is home to a complex community of microorganisms, called the microbiota. The microbiota benefits the host by digesting complex fibers, regulating inflammatory responses, an…

Unclear Biomedical
$646,426
Year: 2022
Infection and Immunity
View Details

PI: King, Irah L

It is becoming increasingly appreciated that the environment we are exposed to immediately after birth can have long-term consequences on our health. Nowhere in the body is this more relevant than th…

Unclear Biomedical
$921,826
Year: 2022
Infection and Immunity
View Details

PI: Macauley, Matthew S

Cell surface carbohydrates, referred to as glycans, cover all cells and play many important physiological roles. On immune cells, immunomodulatory glycan-binding proteins (GBPs) integrate signals fro…

Unclear Biomedical
$860,626
Year: 2022
Infection and Immunity
View Details

PI: Mortha, Arthur

The development of our immune system depends on the microbiota, the collection of all microorganisms living on our body's surfaces. The impact of prokaryotic member in our microbiota on the host immu…

Unclear Biomedical
$661,726
Year: 2022
Infection and Immunity
View Details

PI: Philpott, Dana J

Intestinal inflammation due to infection or diseases like inflammatory bowel disease causes great deal of morbidity and mortality. Our recent work has uncovered a novel pathway in the intestine that …

Unclear Biomedical
$918,000
Year: 2022
Infection and Immunity
View Details

PI: McGeer, Allison J; Kus, Julianne V

As antimicrobial resistance worsens, and hospital care becomes more and more capable of treating complex diseases, fungal infections are emerging worldwide. As they do, antifungal agents (antibiotics…

Unclear Clinical
$1,522,350
Year: 2022
Infection and Immunity
View Details

PI: Ashkar, Ali A

Successful host defense requires tight control of inflammation to mount an effective immune response while limiting damage to the host. Loss of such inflammatory control can result in "cytokine storm…

Unclear Biomedical
$1,044,226
Year: 2022
Infection and Immunity
View Details

PI: Jean, François; Boudreault, Pierre-Luc; Leduc, Richard

Respiratory viruses such as SARS-CoV-2 (the virus causing COVID-19) and Influenza A virus, have inarguably had an enormous impact on human health. Although vaccines have greatly limited COVID-19 and …

Unclear Biomedical
$945,541
Year: 2022
Infection and Immunity
View Details

PI: Ilkow, Carolina S

Oncolytic or "cancer-killing viruses" are a new and exciting class of anti-cancer therapeutic agents not only due to their specific predilection to infect and kill cancer cells but also because these…

Unclear Biomedical
$852,976
Year: 2022
Infection and Immunity
View Details

PI: Diamandis, Eleftherios P

Outer epidermis contains several proteases which collectively orchestrate vital skin functions, such as skin renewal, barrier function and innate immunity. Amongst them, evidence from genetic and bio…

Unclear Biomedical
$336,600
Year: 2022
Infection and Immunity
View Details

PI: Moraes, Trevor F

Multidrug resistant Acinetobacter is a Gram-negative pathogen that is considered to be an "urgent threat" by the CDC as it causes 12000 infections/yr (7300 MDR with no cure) and 500 deaths in the US …

Unclear Biomedical
$868,276
Year: 2022
Infection and Immunity
View Details

PI: Veillette, André

Accumulating evidence indicates that SLAMF7, a molecule expressed at the surface of "innate" immune cells known as macrophages and NK cells, is a useful target for new anticancer immunotherapies. Amo…

Unclear Biomedical
$956,250
Year: 2022
Infection and Immunity
View Details

PI: Frappier, Lori D

Epstein-Barr virus (EBV) infects most people worldwide, persists for a life-time and is a causative agent in several types of lymphoma, gastric carcinoma and nasopharyngeal carcinoma, accounting for …

Unclear Biomedical
$933,300
Year: 2022
Infection and Immunity
View Details

PI: Wright, Gerard D

Antibiotic resistance is a process where disease-causing bacteria acquire or evolve strategies to evade the drug's killing activity. Interventions ranging from the treatment of pneumonia to cancer ch…

Unclear Biomedical
$956,250
Year: 2022
Infection and Immunity
View Details

PI: Manges, Amee R; Javer, Amin R

Chronic sinusitis (CRS) is a common inflammatory condition of the sinuses that affects up to 2.5% of the Canadian population, and is thought to be caused by bacterial infection, resistant biofilms, c…

Unclear Clinical
$516,376
Year: 2022
Infection and Immunity
View Details

PI: Lavender, Kerry J

HIV continues to be a worldwide pandemic, with approximately 37 million people living with the disease and roughly one million deaths annually. AIDS results from a progressive impairment of the immun…

Unclear Biomedical
$879,750
Year: 2022
Infection and Immunity
View Details

PI: Brooks, David

Central to immune alterations in the tumor microenvironment (TME) that facilitate tumor growth is the functional attenuation (exhaustion) of CD8 T cells. As a result, restoring function to CD8 T cell…

Unclear Biomedical
$1,118,814
Year: 2022
Infection and Immunity
View Details

PI: Botelho, Roberto J

Macrophages are a diverse group of immune cells that play a major role in eliminating dangerous particles like bacteria, pollutants, and even tumour and dead cells. Macrophages do this by recognizing…

Unclear Biomedical
$837,676
Year: 2022
Infection and Immunity
View Details

PI: Anderson, Colin C; Baldwin, Troy A

It is being increasingly found that factors that occur very early in life can promote the generation of disease later in life, and this is also true for autoimmune diseases. Our research focuses on t…

Unclear Biomedical
$895,050
Year: 2022
Infection and Immunity
View Details

PI: Money, Deborah M

There are very little data on human papillomavirus (HPV) vaccination among the 18 million women living with HIV (WLWH) globally, who constitute a population most vulnerable to HPV and the resultant c…

Unclear Clinical
$1,606,500
Year: 2022
Infection and Immunity
View Details

PI: Poon, Arthur F

One of the positive outcomes of the ongoing SARS-CoV-2 pandemic has been the rapid collection and sharing of virus genomc data. Today, there are over 9 million SARS-CoV-2 genomes from around the worl…

Unclear Not applicable / Specifi…
$596,700
Year: 2022
Infection and Immunity
View Details